Kelly Bliss - 29 Aug 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: President, U.S. Group Health
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 29 Aug 2025
Net transactions value: -$35,650
Form type: 4
Filing time: 03 Sep 2025, 16:05:29 UTC
Previous filing: 03 Jun 2025
Next filing: 03 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bliss Kelly	President, U.S. Group Health	C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK	/s/ Adam C. Vandervoort, Attorney-in-Fact	03 Sep 2025	0002036989

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+1,189	+2.4%		51,455	29 Aug 2025	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+3,488	+6.8%		54,943	29 Aug 2025	Direct	F2
transaction	TDOC	Common Stock	Options Exercise		+4,858	+8.8%		59,801	29 Aug 2025	Direct	F2
transaction	TDOC	Common Stock	Sale	$35,650	-4,700	-7.9%	$7.58	55,101	02 Sep 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Performance Stock Units	Options Exercise	$0	-1,189	-33%	$0.000000	2,375	29 Aug 2025	Common Stock	1,189		Direct	F1, F4
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-3,488	-33%	$0.000000	6,976	29 Aug 2025	Common Stock	3,488		Direct	F2, F5
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-4,858	-14%	$0.000000	29,151	29 Aug 2025	Common Stock	4,858		Direct	F2, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4	On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5	On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6	On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.